KMT2A and acute lymphoblastic leukemia: For example, an MRD concentration of 0.01 percent in childhood ALL with high-risk genetics (e.g. lysine methyltransferase 2A (MLL) fusions) has the same relapse risk as an MRD concentration of 1 percent in children with hyper-diploidy [133].